NASDAQ:BCPC

Balchem (BCPC) Stock Forecast, Price & News

$124.04

-1.89 (-1.50%)

(As of 09/29/2023 ET)

Compare

Today's Range: $123.46
▼
$126.46
50-Day Range: $123.38
▼
$142.72
52-Week Range: $116.68
▼
$143.88

Volume: 133,181 shs
Average Volume: 101,279 shs
Market Capitalization: $4.00 billion

P/E Ratio: 40.40
Dividend Yield: 0.57%
Price Target: $165.00

Balchem MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 33.0% Upside
$165.00 Price Target
Short Interest: Healthy
0.70% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -1.54
Upright™ Environmental Score
News Sentiment: 1.01
Based on 4 Articles This Week
Insider Trading: Selling Shares
$499,966 Sold Last Quarter
Proj. Earnings Growth: 12.68%
From $3.47 to $3.91 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.94 out of 5 stars

Basic Materials Sector

18th out of 167 stocks

Chemicals & Allied Products Industry

3rd out of 15 stocks

3.5

Analyst's Opinion

Consensus Rating
Balchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $165.00, Balchem has a forecasted upside of 33.0% from its current price of $124.04.
Amount of Analyst Coverage
Balchem has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.70% of the float of Balchem has been sold short.
Short Interest Ratio / Days to Cover
Balchem has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Balchem has recently increased by 5.85%, indicating that investor sentiment is decreasing significantly.

3.3

Dividend Strength

Dividend Yield
Balchem has a dividend yield of 0.56%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Balchem has been increasing its dividend for 12 years.
Dividend Coverage
The dividend payout ratio of Balchem is 23.13%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Balchem will have a dividend payout ratio of 18.16% next year. This indicates that Balchem will be able to sustain or increase its dividend.

2.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Balchem has received a 6.99% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Whey proteins", "Soy proteins", and "Food preservatives" products. See details.
Environmental Sustainability
The Environmental Impact score for Balchem is -1.54.

2.8

News and Social Media Coverage

News Sentiment
Balchem has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.35 average news sentiment score of Basic Materials companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Balchem this week, compared to 2 articles on an average week.
MarketBeat Follows
Only 1 people have added Balchem to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Balchem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $499,966.00 in company stock.
Percentage Held by Insiders
Only 1.77% of the stock of Balchem is held by insiders.
Percentage Held by Institutions
87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Balchem are expected to grow by 12.68% in the coming year, from $3.47 to $3.91 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Balchem is 40.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.95.
Price to Earnings Ratio vs. Sector
The P/E ratio of Balchem is 40.40, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 100.47.
Price to Earnings Growth Ratio
Balchem has a PEG Ratio of 4.03. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Balchem has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Balchem (NASDAQ:BCPC) Stock

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

BCPC Price History

30 days | 90 days | 365 days | Advanced Chart

BCPC Stock News Headlines

September 19, 2023 | msn.com

Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?

September 14, 2023 | fool.com

Balchem (NASDAQ: BCPC)

October 1, 2023 | Chaikin Analytics (Ad)

This Stock Could Go Up 66% or More.

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

September 3, 2023 | finance.yahoo.com

Balchem Corporation's (NASDAQ:BCPC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

July 31, 2023 | seekingalpha.com

Balchem: Still Neutral Considering Both Q2 Results And Outlook

July 29, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) Q2 2023 Earnings Call Transcript

July 29, 2023 | finance.yahoo.com

Q2 2023 Balchem Corp Earnings Call

July 28, 2023 | finance.yahoo.com

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

October 1, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

July 22, 2023 | finance.yahoo.com

Those who invested in Balchem (NASDAQ:BCPC) three years ago are up 36%

July 14, 2023 | finance.yahoo.com

Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 28, 2023

June 6, 2023 | finance.yahoo.com

Balchem Corporation to Present at the Sidoti June 2023 Virtual Small-Cap Conference June 15, 2023

June 5, 2023 | msn.com

HC Wainwright & Co. Maintains Balchem (BCPC) Buy Recommendation

June 5, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN) and Balchem (BCPC)

May 14, 2023 | finance.yahoo.com

Capital Allocation Trends At Balchem (NASDAQ:BCPC) Aren't Ideal

May 1, 2023 | seekingalpha.com

Balchem: A Mixed Quarter

April 29, 2023 | finance.yahoo.com

Q1 2023 Balchem Corp Earnings Call

April 28, 2023 | finance.yahoo.com

Balchem Corporation Reports Record First Quarter Sales of $232.5 Million, with Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.94

April 28, 2023 | seekingalpha.com

Balchem Corporation 2023 Q1 - Results - Earnings Call Presentation

April 27, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 35% Above Their Intrinsic Value Estimate

April 26, 2023 | finance.yahoo.com

Balchem Corporation Releases 2022 Sustainability Report

April 14, 2023 | finance.yahoo.com

Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 28, 2023

March 27, 2023 | finance.yahoo.com

Are Balchem Corporation's (NASDAQ:BCPC) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

March 1, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) Q4 2022 Earnings Call Transcript

February 26, 2023 | finance.yahoo.com

Balchem Full Year 2022 Earnings: EPS Misses Expectations

February 25, 2023 | finance.yahoo.com

Q4 2022 Balchem Corp Earnings Call

February 24, 2023 | finance.yahoo.com

Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results

See More Headlines

Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

BCPC Company Calendar

Last Earnings: 7/28/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/03/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Chemicals & allied products
Sub-Industry: Specialty Chemicals
Sector: Basic Materials
Current Symbol: NASDAQ:BCPC
CUSIP: 05766520
CIK: 9326
Web: www.balchem.com
Phone: (845) 326-5600
Fax: 845-326-5717
Employees: 1,340
Year Founded: 1967

Price Target and Rating

Average Stock Price Forecast: $165.00
High Stock Price Forecast: $165.00
Low Stock Price Forecast: $165.00
Forecasted Upside/Downside: +33.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.07
Trailing P/E Ratio: 40.40
Forward P/E Ratio: 35.75
P/E Growth: 4.03
Net Income: $105.37 million
Net Margins: 10.58%
Pretax Margin: 13.22%
Return on Equity: 10.43%
Return on Assets: 6.12%

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 2.94
Quick Ratio: 1.85

Sales & Book Value

Annual Sales: $942.36 million
Price / Sales: 4.24
Cash Flow: $4.82 per share
Price / Cash Flow: 25.74
Book Value: $29.20 per share
Price / Book: 4.25

Miscellaneous

Outstanding Shares: 32,240,000
Free Float: 31,669,000
Market Cap: $4.00 billion
Optionable: Optionable
Beta: 0.69

Social Links

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Theodore L. Harris (Age 58)
Chairman, CEO & Pres
Comp: $2.33M

Mr. Carl Martin Bengtsson (Age 45)
Exec. VP, CFO & Treasurer
Comp: $864.13k

Ms. Hatsuki Miyata (Age 47)
Exec. VP, Gen. Counsel & Sec.
Comp: $618.21k

Mr. Jonathan H. Griffin (Age 47)
Sr. VP and GM of Animal Nutrition & Health
Comp: $624.01k

Mr. Martin Luther Reid (Age 55)
Sr. VP & Chief Supply Chain Officer
Comp: $672.26k

Mr. William A. Backus CPA (Age 57)
CPA, VP & CAO

Mr. Michael R. Sestrick Ph.D. (Age 59)
Sr. VP & CTO

Mr. Brent Tignor (Age 45)
Sr. VP & Chief HR Officer

Mr. Frederic Boned (Age 45)
Sr. VP and GM of Human Nutrition & Health

Mr. Job L. van Gunsteren (Age 47)
Sr. VP & GM of Specialty Products

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BCPC Stock - Frequently Asked Questions

Should I buy or sell Balchem stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings or view top-rated stocks.
What is Balchem's stock price forecast for 2023?: 1 Wall Street research analysts have issued twelve-month price objectives for Balchem's stock. Their BCPC share price forecasts range from $165.00 to $165.00. On average, they expect the company's stock price to reach $165.00 in the next twelve months. This suggests a possible upside of 33.0% from the stock's current price.
View analysts price targets for BCPC or view top-rated stocks among Wall Street analysts.
How have BCPC shares performed in 2023?: Balchem's stock was trading at $122.11 at the beginning of 2023. Since then, BCPC stock has increased by 1.6% and is now trading at $124.04.
View the best growth stocks for 2023 here.
Are investors shorting Balchem?: Balchem saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 222,600 shares, an increase of 5.8% from the August 31st total of 210,300 shares. Based on an average daily volume of 85,300 shares, the short-interest ratio is presently 2.6 days. Approximately 0.7% of the shares of the company are sold short.
View Balchem's Short Interest.
When is Balchem's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, November 3rd 2023.
View our BCPC earnings forecast.
How were Balchem's earnings last quarter?: Balchem Co. (NASDAQ:BCPC) posted its quarterly earnings data on Friday, July, 28th. The basic materials company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.80 by $0.13. The basic materials company had revenue of $231.25 million for the quarter, compared to analyst estimates of $241 million. Balchem had a net margin of 10.58% and a trailing twelve-month return on equity of 10.43%.
How often does Balchem pay dividends? What is the dividend yield for Balchem?: Balchem announced an annual dividend on Tuesday, December 6th. Shareholders of record on Tuesday, December 27th will be paid a dividend of $0.71 per share on Friday, January 20th. This represents a yield of 0.53%. The ex-dividend date is Friday, December 23rd. This is a positive change from the stock's previous annual dividend of $0.64.
Read our dividend analysis for BCPC.
What ETFs hold Balchem's stock?: ETFs with the largest weight of Balchem (NASDAQ:BCPC) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM), Subversive Food Security ETF (KCAL), VanEck Future of Food ETF (YUMY), iShares S&P Small-Cap 600 Growth ETF (IJT), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), SPDR S&P 600 Small Cap Growth ETF (SLYG), VanEck Agribusiness ETF (MOO) and SPDR S&P SmallCap 600 ESG ETF (ESIX).

Is Balchem a good dividend stock?: Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.56%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 18.16% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.
What is Dino A. Rossi's approval rating as Balchem's CEO?: 25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.
What other stocks do shareholders of Balchem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).
What is Balchem's stock symbol?: Balchem trades on the NASDAQ under the ticker symbol "BCPC."
How do I buy shares of Balchem?: Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Balchem's stock price today?: One share of BCPC stock can currently be purchased for approximately $124.04.
How much money does Balchem make?: Balchem (NASDAQ:BCPC) has a market capitalization of $4.00 billion and generates $942.36 million in revenue each year. The basic materials company earns $105.37 million in net income (profit) each year or $3.07 on an earnings per share basis.
How many employees does Balchem have?: The company employs 1,340 workers across the globe.
Does Balchem have any subsidiaries?: The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..
Read More
How can I contact Balchem?: Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717.

This page (NASDAQ:BCPC) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial